| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |